₨ NPR
GLIZID MR 60
GLIZID MR 60 (Gliclazide 60 mg) is a modified-release sulfonylurea used to treat type 2 diabetes mellitus in adults. It stimulates insulin release from the pancreas, lowering blood sugar levels and preventing complications like kidney damage, neuropathy, or blindness. Taken orally, usually with breakfast, it ensures steady glucose control.
₨119.79
Ask about productDescription
GLIZID MR 60 (Gliclazide 60 mg) is a modified-release sulfonylurea used to treat type 2 diabetes mellitus in adults. It stimulates insulin release from the pancreas, lowering blood sugar levels and preventing complications like kidney damage, neuropathy, or blindness. Taken orally, usually with breakfast, it ensures steady glucose control. Suitable when diet and exercise alone are insufficient, it is often prescribed alone or with other antidiabetics. Common side effects include hypoglycemia, nausea, and constipation, while serious risks like liver issues or severe allergic reactions require monitoring. It is contraindicated in type 1 diabetes, severe kidney/liver disease, or pregnancy. Avoid alcohol, as it increases hypoglycemia risk. Regular blood sugar and liver function monitoring is essential. Consult a doctor for use in breastfeeding or with kidney issues, and maintain a healthy diet and exercise regimen for optimal results.
Uses:
- Controls blood sugar in type 2 diabetes.
- Prevents diabetes-related complications.
- Enhances insulin secretion.
Precautions:
- Avoid alcohol to prevent hypoglycemia.
- Monitor blood sugar regularly.
- Consult a doctor if pregnant or breastfeeding.
Reviews
There are no reviews yet.